Source: Annual Congress 2010 - Lung cancer, idiopathic pulmonary fibrosis and sarcoidosis: the genetic approach
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Skronski, P. Jagus, A. Szpechcinski, R. Struniawski, J. Chorostowska-Wynimko (Warsaw, Poland). Late Breaking Abstract: Real-time PCR versus direct sequencing in detection of EGFR T790M and L858R mutations – The sensitivity comparison. Eur Respir J 2010; 36: Suppl. 54, 3546

Member's Comments

No comment yet.

Related content which might interest you: Evaluation of PNA-LNA PCR clamp method sensitivity for detection of key EGFR gene exon 19 and exon 21 mutations Source: Annual Congress 2012 - New results in molecular pathology and functional genomics of neoplastic and non-neoplastic lung disease Year: 2012 Diagnostic utility of PNA-LNA PCR clamp method for detection of EGFR exon 19 deletions and exon 21 codon L858 mutations in NSCLC samples with low tumor cells content Source: Annual Congress 2012 - New results in molecular pathology and functional genomics of neoplastic and non-neoplastic lung disease Year: 2012 Evaluation of highly sensitive PNA-LNA PCR clamp method for EGFR L858R mutation detection in lung adenocarcinoma patients Source: Annual Congress 2011 - Lung cancer: molecular pathology and functional genomics Year: 2011 Detection of isoniazid resistance mutations in Mycobacterium tuberculosis by use of sequencing, PCR-RFLP and TaqMan probes Source: Annual Congress 2010 - Tuberculosis drug resistance Year: 2010 LATE-BREAKING ABSTRACT: Novel rapid screening assay for HER2 duplicated insertion mutation by Eprobe-PCR method Source: International Congress 2015 – Diagnosis and therapy of lung cancer Year: 2015 Target other gene point mutations: HER2 and rare EGFR mutations Source: ERS Research Seminar Year: 2015 Evaluation of four different molecular methods for EGFR mutation analysis in exon 18, 19 and 21 Source: Annual Congress 2011 - Lung cancer: molecular pathology and functional genomics Year: 2011 Allele-specific real-time PCR detection of EGFR exon 19 and 21 mutations in various clinical non-small cell lung cancer specimens Source: International Congress 2014 – Basic and translational research in lung cancer and non-neoplastic pulmonary diseases Year: 2014 Validation of PNA-LNA PCR clamp assay for detection of EGFR exon 19 and 21 mutations in various types of clinical non-small cell lung cancer specimens Source: Annual Congress 2013 –Translational research to bridge the need within clinical decision making Year: 2013 Detection of rifampin resistance mutations in Mycobacterium tuberculosis by use of sequencing, molecular beacons and taqman probes Source: Annual Congress 2009 - Diagnostic advances in tuberculosis Year: 2009 Noninvasive detection of EGFR T790M mutation in gefitinib resistant non-small cell lung cancer using mutant-enriched PCR Source: Annual Congress 2013 –New methods for diagnostic workup of lung cancer Year: 2013 Clinical value of IS6110-based loop-mediated isothermal amplification (IS6110-LAMP) for direct detection of Mycobacterium tuberculosis complex in respiratory specimens Source: Annual Congress 2010 - Tuberculosis drug resistance Year: 2010 The detection of EGFR mutations in liquid biopsy by allele-specific qPCR – the comparative evaluation of two common diagnostic tests Source: International Congress 2018 – Genetics in chronic pulmonary diseases Year: 2018 LATE-BREAKING ABSTRACT: Reliability of EGFR mutations detection in NSCLC brain metastases by two different allele-specific PCR methods Source: Annual Congress 2012 - New mechanisms in non-neoplastic and neoplastic lung diseases Year: 2012 Frequency and clinical-tomographic characterization of NSCLC with T790M mutation to TKI progression. Source: International Congress 2019 – Diagnosis of lung cancer Year: 2019 Rapid detection of M. tuberculosis gene mutations associated with drug resistance by modified allele-specific real-time PCR Source: Eur Respir J 2006; 28: Suppl. 50, 589s Year: 2006 RT-PCR and IHC as the alternative methods for detection of ALK aberrations in NSCLC samples - The feasibility study Source: International Congress 2015 – Promising novel findings in translational pulmonary research Year: 2015 Gefitinib as first-line treatment for patients with NSCLC with activating EGFR mutationin exons 19 (Del19) or 21 (L858R) in the Czech Republic Source: International Congress 2015 – Lung cancer therapy: clinical trials Year: 2015 Development a set of reagents for real-time PCR diagnostics and surveillance of infections caused by B. pertussis, B. parapertussis and B. bronchiseptica Source: Annual Congress 2011 - Paediatric respiratory infection: signs, symptoms and sequelae Year: 2011 EGFR, KRAS, HER2, BRAF and PI3KCA mutation status in metastatic cancer patients: Thoracic cytological specimens obtained in routine clinical practice Source: Annual Congress 2013 –Progress in bronchoscopy and pathology techniques for diagnosis of thoracic malignancies Year: 2013